Back to "Alirocumab reduced MI, 0.57 (0.38, 0.86,..."
Strong Support
causal
Analysis v1
History

A drug called alirocumab may help prevent serious heart problems and even lower the chance of dying from heart disease in people at high risk — but we’re still not totally sure about the...

59
Pro
0
Against

Evidence from Studies

Supporting (1)

59

Community contributions welcome

59

Proprotein convertase subtilisn/kexin type 9 inhibitors and small interfering RNA therapy for cardiovascular risk reduction: A systematic review and meta-analysis

Systematic Review With Meta-Analysis
Human
2023

Contradicting (0)

0

Community contributions welcome

No contradicting evidence found

Gold Standard Evidence Needed

According to GRADE and EBM methodology, here is what ideal scientific evidence would look like to definitively prove or disprove this specific claim, ordered from strongest to weakest evidence.

Sign up to see full verdict

Source Study

Proprotein convertase subtilisn/kexin type 9 inhibitors and small interfering RNA therapy for cardiovascular risk reduction: A systematic review and meta-analysis

Score: 59
DOI: 10.1371/journal.pone.0295359

Similar Assertions

A drug called Evolocumab helps lower the chance of serious heart problems like heart attacks and strokes in people at high risk — and it seems to work pretty well over about 8 months.

59
0
81%

Taking certain cholesterol drugs called evolocumab or alirocumab may help lower the chance of heart problems, whether you've already had heart issues or are just trying to prevent them.

38
0
80%

A drug called alirocumab, given as a 75mg shot every couple of weeks, lowered bad cholesterol by almost half in people at high risk for heart problems over six months — a bit less than another similar drug, evolocumab.

59
0
78%

Taking certain cholesterol drugs called evolocumab or alirocumab might lower the chance of having a stroke, whether you've already had heart problems or not.

38
0
72%

For people with serious heart disease who are already taking cholesterol-lowering pills, adding one of two special drugs (evolocumab or alirocumab) can lower their chances of having a major heart problem—like a heart attack—by about 15% over a few years.

1
0
71%